The siRNA–FAK reduces theresistance of ovarian cancer cells to chemotherapy and paclitaxelinduces apoptosis in cancer cells.316 Effluxtransporters and Bcl-2 are the most common targets used to rendercancerous cells more susceptible to paclitaxel chemotherapy. Here, BCL2 is linked to cancer.